Y-MABS THERAPEUTICS, INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 11.98 USD | -2.68% |
|
-0.99% | +75.66% |
| Jun. 05 | Y-mAbs Therapeutics, Inc. Appoints Norman LaFrance as Chief Development Officer | CI |
| Jun. 01 | Y-mAbs Therapeutics, Inc. Announces Publication of Preclinical GD2-SADA Data | CI |
Quotes 5-day view
Delayed Quote Nasdaq| 2024-06-04 | 2024-06-05 | 2024-06-06 | 2024-06-07 | |
|---|---|---|---|---|
| Last | 12.02 $ | 12.73 $ | 12.31 $ | 11.98 $ |
| Volume | 196 260 | 348 325 | 384 406 | 242 420 |
| Change | -0.41% | +5.91% | -3.30% | -2.68% |
| Opening | 12.09 | 12.06 | 12.73 | 12.20 |
| High | 12.42 | 12.74 | 12.92 | 12.55 |
| Low | 11.80 | 11.77 | 12.13 | 11.81 |
Performance
| 1 day | -2.68% | ||
| 1 week | -0.99% | ||
| Current month | -0.99% | ||
| 1 month | -6.92% | ||
| 3 months | -32.01% | ||
| 6 months | +69.21% | ||
| Current year | +75.66% | ||
| 1 year | +46.63% | ||
| 3 years | -67.07% | ||
| 5 years | -44.54% |
Volumes
marketsDaily volume
242 420
Estimated daily volume
242 420
Avg. Volume 20 sessions
360 189
Daily volume ratio
0.67
Avg. Volume 20 sessions USD
4 315 064.22
Record volume 1
18 805 000
Record volume 2
12 286 760
Record volume 3
5 220 572
Capital turnover ratio
0.01
Float rotation
0.01
Basic data
Capitalization (USD)
525 714 003
Net sales (USD)
84 819 000
Number of employees
100
Sales / Employee (USD)
848 190
Free-Float
87.74 %
Free-Float capitalization (USD)
461 279 849
Average Daily Capital Traded
0.82%
Highs and lows
1 week
11.77
12.92
1 month
11.1513.25
Current year
6.4820.90
1 year
4.6020.90
3 years
2.7039.82
5 years
2.7055.22
10 years
2.7055.22
Indicators
Moving average 5 days
12.22
Moving average 20 days
12.22
Moving average 50 days
14.06
Moving average 100 days
14.28
Price spread / (MMA5)
+2.02%
Price spread / (MMA20)
+1.97%
Price spread / (MMA50)
+17.37%
Price spread / (MMA100)
+19.21%
STIM
RSI 9 days
45.18
RSI 14 days
42.96
Sector Comparison - Bio Therapeutic Drugs
| Name | Change | 5d. change | 1st Jan change | 1-year change | Capi. | |
|---|---|---|---|---|---|---|
| -2.68% | -0.99% | +75.66% | +46.63% | 526M | ||
| -0.51% | +6.08% | +18.72% | +44.58% | 125B | ||
| +0.22% | +2.33% | +14.19% | +34.35% | 108B | ||
| -1.44% | -0.26% | -4.93% | -8.16% | 24.21B | ||
| -0.87% | +1.30% | +2.45% | -4.89% | 22.78B | ||
| -0.05% | -1.20% | -10.44% | -28.52% | 17.96B | ||
| -0.45% | +0.66% | -41.74% | -37.14% | 16.43B | ||
| -0.79% | +5.05% | -13.31% | -27.62% | 16.37B | ||
| +1.43% | -0.32% | +2.44% | +44.52% | 13.58B | ||
| +5.01% | -5.04% | +27.89% | -3.41% | 11.66B | ||
| -0.56% | +3.27% | +83.45% | +187.12% | 9.17B | ||
| -2.13% | +13.90% | -24.26% | -32.61% | 8.31B | ||
| -0.96% | +1.53% | +8.91% | +48.04% | 7.87B | ||
| -2.12% | +1.00% | +13.01% | +40.37% | 7.72B | ||
| -0.60% | -1.77% | -5.61% | +21.90% | 7.29B | ||
| -1.15% | +14.81% | +37.58% | +49.73% | 6.47B | ||
| Average | -0.47% | +2.76% | +11.50% | +23.43% | ||
| Weighted average by Cap. | -0.24% | +3.40% | +10.04% | +26.28% |
Historical data
| Date | Opening | High | Low | End-of-day | Volume |
|---|
Last transactions
e0466026c34a981.bhwlWPvUS0YXVyN96fs5VWcKGM752jI7nCLUYsjn-DQ.G1RDDJSMGjZhYls5sb9JBx5GSP-07mhW1FO5MPG_iWwWW2serOcPP04Nbg
| Date | Price | Volume | Daily volume |
|---|---|---|---|
| 04:00:00 pm | 11.98 | 24,980 | 183,008 |
| 03:59:58 pm | 11.98 | 100 | 158,028 |
| 03:59:58 pm | 12 | 108 | 157,928 |
| 03:59:56 pm | 12 | 100 | 157,820 |
| 03:59:51 pm | 12 | 200 | 157,720 |
| 03:59:51 pm | 12 | 100 | 157,520 |
| 03:59:46 pm | 11.98 | 100 | 157,420 |
| 03:59:45 pm | 11.99 | 100 | 157,320 |
| 03:59:45 pm | 11.99 | 100 | 157,220 |
| 03:59:45 pm | 11.99 | 100 | 157,120 |
Monthly variations
Annual change
| 2024 | +75.66% | ||
| 2023 | +39.75% | ||
| 2022 | -69.90% | ||
| 2021 | -67.26% | ||
| 2020 | +58.43% | ||
| 2019 | +53.64% | ||
| 2018 | -15.25% |
- Stock Market
- Equities
- YMAB Stock
- Quotes Y-mAbs Therapeutics, Inc.
